Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Agile Therapeutics Stock Forecast NASDAQ:AGRX
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-04-08 | - | Maxim Group | - | Downgrades | Buy Hold |
| 2021-11-03 | 79.86% | HC Wainwright & Co. | $3.50 $2.50 | Maintains | Buy |
| 2021-09-13 | 151.8% | HC Wainwright & Co. | $7.00 $3.50 | Maintains | Buy |
| 2021-07-27 | 259.71% | RBC Capital | $6.00 $5.00 | Maintains | Outperform |
| 2020-12-08 | 403.6% | HC Wainwright & Co. | $6.00 $7.00 | Maintains | Buy |
| 2020-03-20 | 331.65% | HC Wainwright & Co. | $7.00 $6.00 | Reiterates | Buy |
| 2020-02-18 | 403.6% | HC Wainwright & Co. | $5.00 $7.00 | Maintains | Buy |
| 2020-02-18 | 475.54% | RBC Capital | $5.00 $8.00 | Maintains | Outperform |
| 2019-06-07 | 259.71% | Oppenheimer | $5.00 | Initiates Coverage On | Outperform |
AGRX Stock Trend
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 93.53% during the next 3 months and, with a 90% probability hold a price between $1.15 and $6.96 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $0.62 | $2.12 | $3.62 |
| 2022-05-24 | $0.65 | $2.15 | $3.65 |
| 2022-05-25 | $0.68 | $2.18 | $3.68 |
| 2022-05-26 | $0.71 | $2.21 | $3.71 |
| 2022-05-27 | $0.74 | $2.24 | $3.74 |
| 2022-05-31 | $0.77 | $2.27 | $3.77 |
| 2022-06-01 | $0.80 | $2.30 | $3.80 |
| 2022-06-02 | $0.82 | $2.32 | $3.82 |
| 2022-06-03 | $0.85 | $2.35 | $3.85 |
| 2022-06-06 | $0.88 | $2.38 | $3.88 |
| 2022-06-07 | $0.91 | $2.41 | $3.91 |
| 2022-06-08 | $0.94 | $2.44 | $3.94 |
| 2022-06-09 | $0.97 | $2.47 | $3.97 |
| 2022-06-10 | $1.00 | $2.49 | $3.99 |
| 2022-06-13 | $1.02 | $2.52 | $4.02 |
| 2022-06-14 | $1.05 | $2.55 | $4.05 |
| 2022-06-15 | $1.08 | $2.58 | $4.08 |
| 2022-06-16 | $1.11 | $2.61 | $4.11 |
| 2022-06-17 | $1.14 | $2.64 | $4.14 |
| 2022-06-21 | $1.17 | $2.67 | $4.17 |
| 2022-06-22 | $1.19 | $2.69 | $4.19 |
| 2022-06-23 | $1.22 | $2.72 | $4.22 |
| 2022-06-24 | $1.25 | $2.75 | $4.25 |
| 2022-06-27 | $1.28 | $2.78 | $4.28 |
| 2022-06-28 | $1.31 | $2.81 | $4.31 |
| 2022-06-29 | $1.34 | $2.84 | $4.34 |
| 2022-06-30 | $1.37 | $2.87 | $4.36 |
| 2022-07-01 | $1.39 | $2.89 | $4.39 |
| 2022-07-05 | $1.42 | $2.92 | $4.42 |
| 2022-07-06 | $1.45 | $2.95 | $4.45 |
Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cyc... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
